Point72 Europe »

Contineum Therapeutics shares owned by Point72 Europe

Quarter-by-quarter ownership of Contineum Therapeutics (CTNM) shares owned by Point72 Europe from 13F filings

Historical chart of Point72 Europe investment in Contineum Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Contineum Therapeutics held by Point72 Europe consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Contineum Therapeutics by Point72 Europe

Quarter filed Position value Share count Share price at filing
2025-09-30 $2.1k 179 11.74

More positions owned by Point72 Europe

Strategy Cl A New (MSTR)
Alphabet Cap Stk Cl A (GOOGL)
Amazon (AMZN)
Meta Platforms Cl A (META)
Capital One Financial (COF)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Ishares Tr Russell 2000 Etf (IWM)
Key (KEY)
Charles Schwab Corporation (SCHW)
TPG Com Cl A (TPG)
WESCO International (WCC)
Bank of America Corporation (BAC)
Regeneron Pharmaceuticals (REGN)
Suncor Energy (SU)
Linde SHS (LIN)

View all positions for Point72 Europe

Top funds holding Contineum Therapeutics

RA Capital Management
Johnson & Johnson
Suvretta Capital Management
Franklin Resources
Vanguard Group
Balyasny Asset Management
FMR
Sectoral Asset Management
Perceptive Advisors
Hillhouse Capital Advisors
Millennium Management
Red Tree Management
Samsara BioCapital
Versant Venture Management
Point72 Asset Management

View all funds holding Contineum Therapeutics